Biểu đồ giá cổ phiếu APGE
APGE Giá
Apogee Therapeutics Inc
$80.75
-2.58%
$-2.14
Khi đóng cửa: May 01, 16:00:00 GMT-4
$80.3
-0.55%
$-0.45
Phiên sau giờ: May 01, 20:00:00 GMT-4
Quay lại
Apogee Therapeutics Inc (APGE) Giá
Thống kê chính
Giá đóng cửa trước
$82.89
Giá mở cửa
$83.99
Phạm vi ngày
$80.3 - $84.06
Phạm vi 52 tuần
$31.21 - $88.35
Khối lượng
342.7K
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
--
EPS (TTM)
-4.22
Vốn hóa thị trường
$5.9B
APGE là gì?
Apogee Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Waltham, Massachusetts and currently employs 261,000 full-time employees. The company went IPO on 2023-07-14. The firm is advancing novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. APG777, the Company’s most advanced program, is being initially developed for the treatment of AD. With four validated targets in its portfolio, it is seeking to achieve efficacy and dosing through monotherapies and combinations of its novel antibodies. Its most advanced programs are APG777, APG990, APG333, and APG808. APG990 is an SQ extended half-life mAb that utilizes advanced antibody engineering to target OX40L. APG333 is a fully human mAb against thymic stromal lymphopoietin (TSLP). APG808 is an SQ extended half-life mAb targeting IL-4Rα. APG279 is for the dual inhibition of OX40L and IL-13.
